Patents Issued in May 27, 2014
-
Patent number: 8735131Abstract: An object is to provide a novel method for improving an enzyme capable of deamidating a protein. A mutant protein deamidase is designed by the following steps: (A) identifying one or more amino acid in an amino acid sequence for a protein deamidase which corresponds to the amino acid at position 35, 38 to 43, 45, 46, 49, 79 to 84, 103 to 106, 117, 142, 143, 146, 166, or 185 in the amino acid sequence set forth in SEQ ID NO: 2; and (B) constructing a mutant amino acid sequence of the protein deamidase by substituting the one or more amino acid identified in step (A) with another amino acid or other amino acids or by deleting the one or more amino acid identified in step (A).Type: GrantFiled: August 12, 2009Date of Patent: May 27, 2014Assignee: Amano Enzyme Inc.Inventors: Ryota Hashizume, Bunzo Mikami, Hirotaka Matsubara, Akiko Matsunaga, Shotaro Yamaguchi
-
Patent number: 8735132Abstract: The invention relates to identification of mutations and genetic targets for enhanced L-tyrosine production, and bacterial strains capable of L-tyrosine production.Type: GrantFiled: May 5, 2011Date of Patent: May 27, 2014Assignee: Massachusetts Institute of TechnologyInventors: Christine Santos, Gregory Stephanopoulos
-
Patent number: 8735133Abstract: Described herein are molecules, constructs and methods for the production and secretion of polypeptides of interest by host cells, preferably bacterial host cells, and more particularly gram positive bacteria. In particular, the present invention is related to a polynucleic acid encoding a fusion protein and to uses thereof for the secretion of heterologous or homologous polypeptides of interest by a bacterial host cell, preferably Clostridium bacteria. The present invention further relates to methods and constructs for the production and secretion of heterologous or homologous polypeptides of interest proteins by host cells using such polynucleic acids and fusion proteins.Type: GrantFiled: July 30, 2009Date of Patent: May 27, 2014Inventors: Henri-Pierre Fierobe, Florence Mingardon, Angélique Chanal-Vial
-
Patent number: 8735134Abstract: The present invention provides methods and compositions of variant polypeptides having isoprene synthase activity with improved solubility. In particular, the present invention provides isoprene synthase variant for increased isoprene production in recombinant host cells.Type: GrantFiled: October 26, 2012Date of Patent: May 27, 2014Assignees: Danisco US Inc., The Goodyear Tire & Rubber CompanyInventors: Christopher L. Rife, Derek H. Wells
-
Patent number: 8735135Abstract: Disclosed is a means for improving the poor conversion efficiency in a conventional bioconversion system using a transformant which is given by introducing a gene originated from xerogenic organisms. A transformant is prepared by using a host which is defective in a gene encoding a multidrug efflux protein and introducing a gene originated from xerogenic organisms. Use of the transformant results in much effective microbial conversion of a hydrophobic or amphipathic substrate compound into a desired compound. In case, an Escherichia coli is used as the host, the gene encoding a multidrug efflux protein to be defective may be tolC, acrA, acrB and the like.Type: GrantFiled: February 28, 2008Date of Patent: May 27, 2014Assignee: Microbiopharm Japan Co., LtdInventors: Tadashi Fujii, Atsushi Ochiai, Masashi Ito, Hiroki Kabumoto, Yoshikazu Fujii, Kazuhiro Machida
-
Patent number: 8735136Abstract: Substantially pure biological culture of a strain of the species Pseudomonas graminis, deposited with number CBS136973 at the depositary institution “Centraalbureau voor Schimmelcultures” (CBS) in Utrecht, Netherlands. Use of the CBS136973 culture as an antagonist for the biocontrol of foodborne pathogenic bacteria in fruit intended for human consumption. Method for treating the fruit which comprises the step of applying a preparation that comprises a culture of a strain of the species Pseudomonas graminis, deposited with number CBS136973 at the depositary institution “Centraalbureau voor Schimmelcultures” (CBS) in Utrecht, Netherlands, to the fruit. The application thereof makes it possible to reduce the growth of pathogens during the shelf life of the product, especially when the cold chain is broken.Type: GrantFiled: December 29, 2011Date of Patent: May 27, 2014Assignees: Institut de Recerca I Tecnologia Agroalimentaries, Universitat de LleidaInventors: Immaculada Vinas Almenar, Maria Isabel Abadias Sero, Josep Usall Rodie, Neus Teixido Espasa, Rosario Torres Sanchis
-
Patent number: 8735137Abstract: Disclosed herein are transformed Yarrowia lipolytica comprising an exogenous polynucleotide encoding a polypeptide having sucrose invertase activity. Also disclosed are methods of using the transformed Y. lipolytica.Type: GrantFiled: November 15, 2011Date of Patent: May 27, 2014Assignee: E I du Pont de Nemours and CompanyInventors: Seung-Pyo Hong, John E. Seip, Quinn Qun Zhu
-
Patent number: 8735138Abstract: The present invention relates to methods for producing Saccharomyces strains that are capable of growth on xylose as a sole carbon source at a desired growth rate (such as at least one generation per 48 hours), strains made by such methods, and Saccharomyces strains that grow at a growth rate of at least one generation per 48 hours using xylose as a sole carbon source for growth made by non-recombinant methods.Type: GrantFiled: September 16, 2009Date of Patent: May 27, 2014Assignee: Microbiogen Pty LtdInventors: Philip John Bell, Paul Victor Attfield
-
Patent number: 8735139Abstract: The present invention is a method for fermentation of algae or algaefaction method. The method includes feeding a hydrocarbon composition into a gasifier and pre-heating a biomass stream from a fermentation reactor. The biomass stream includes a liquid portion, a catalyst, and a biomass solids portion ranging between 15-92% by weight of the biomass stream. The biomass solids portion is algae or algal solids. The biomass stream is pre-heated to a temperature range between 200° F. and 500° F. Both the syngas and the pre-heated biomass stream are injected as a mixture into a reactor, where the mixture is separated into a gas component, liquid component, and solids component. The solids component is algal crude, which can be collected for processing as transportation fuels. The gas component is a lower temperature syngas, which can also be collected for processing as electricity or transportation fuels.Type: GrantFiled: November 18, 2011Date of Patent: May 27, 2014Assignee: Missing Link Technology, LLCInventors: Tommie Merimon, Jerry McCall
-
Patent number: 8735140Abstract: The present invention relates to compositions and uses of a novel Dunaliella salina HT04 microorganism. In addition, the present invention relates to novel methods for culturing harvesting, preservation, storage, and production of algae seedstock and uses thereof.Type: GrantFiled: January 30, 2012Date of Patent: May 27, 2014Assignee: Kuehnle AgroSystems, Inc.Inventor: Adelheid R. Kuehnle
-
Patent number: 8735141Abstract: A biodegradable wellbore fluid with an oleaginous phase including a linear paraffin having 11-18 carbon atoms, a non-oleaginous phase, an emulsifying agent and optionally a weighting agent. Use of the fluid while drilling allows bio-remediation of drill cuttings using land spreading, bioreactors, conventional composting or vermiculture composting. The resulting product, especially when vermicomposed, is potentially useful as a soil amendment or plant fertilizer material.Type: GrantFiled: November 15, 2004Date of Patent: May 27, 2014Assignee: M-I L.L.C.Inventors: Frederick Growcock, G. Wray Curtis, John Candler, Stephen Rabke, Sonya Ross, Jonathan Getliff, Greg McEwan
-
Patent number: 8735142Abstract: The present invention discloses systems and methods for minimizing or eliminating steps in immunosorbent assays for single and multiple analytes by eliminating both the need to attach target molecules to the test well and the need to remove unbound antibodies through rinsing. The immunosorbent assay (ISA) is utilized for a single analyte or target and includes the step of mixing the immunologic molecules with the sample and detection. The present invention further discloses an immunosorbent assay for multiple analytes (ISAMA) for testing a plurality of analytes or targets in a single well using a modified ISA test wherein different tags are attached to different antibody pairs. Alternate embodiments use multiple types of scavenger antigens with corresponding elimination of the need for scavenger antibodies. The present invention discloses various types of test wells for the rapid and simultaneous testing of fluids for a plurality of components and a methodology for a continuous immunosorbent assay.Type: GrantFiled: August 2, 2010Date of Patent: May 27, 2014Assignee: Chipotle Business Group, Inc.Inventors: Derrick Charbonnet, Norman Scott Evans
-
Patent number: 8735143Abstract: The present invention provides a hepatic lobule-like bioreactor. The bioreactor includes a nanofiber scaffold enclosed within a housing. An intrahepatic fibrous vascular network, a bile capillary network, upper hepatic bile ducts, lower hepatic bile ducts, a common bile duct connecting the upper and the lower hepatic bile ducts, and collagen fibrous microchannels for hepatocytes surrounded by the bile capillary network are distributed throughout the nanofiber scaffold. Bile capillaries in the bile capillary network are provided with two or more inlet ports for biliary epithelial cells. The collagen fibrous microchannels for hepatocytes are provided with two or more inlet ports for hepatocytes. The intrahepatic vascular network is provided with a liquid inlet port and a liquid outlet port. These ports extend through the housing.Type: GrantFiled: March 21, 2011Date of Patent: May 27, 2014Assignee: Zhejiang UniversityInventors: Lanjuan Li, Chengbo Yu, Yiming Zhang, Xiaoping Pan, Weibo Du, Hongcui Cao, Guoliang Lv, Jianrong Huang
-
Patent number: 8735144Abstract: Embodiments of the invention provide a bioreactor chamber assembly comprising: a bioreactor chamber comprising first and second portions arranged to be coupled to one another thereby to provide a liquid-tight seal therebetween; a pair of clamp members; and a pair of resilient loop elements, wherein the clamp members are arranged to sandwich the chamber between the clamp members and the loop elements are arranged to apply a force between the clamp members to urge the first and second portions together.Type: GrantFiled: July 31, 2009Date of Patent: May 27, 2014Assignee: Kirstall LimitedInventors: Arti Ahluwalia, Daniele Mazzei, Bruna Vinci
-
Patent number: 8735145Abstract: The present invention provides an array of compositions useful for effecting and/or exhibiting changes in biological functioning and processing within cells and in biological systems containing such cells. In effect, these compositions combine chemical modifications and/or ligand additions with biological functions. The chemical modifications and/or ligand additions provide additional characteristics to the compositions without interfering substantially with their biological function. Such additional characteristics include nuclease resistance, targeting specific cells or specific cell receptors localizing to specific sites within cells and augmenting interactions between the compositions and target cells of interest as well as decreasing such interactions when desired. Also provided by the present invention are processes and kits.Type: GrantFiled: October 30, 2007Date of Patent: May 27, 2014Assignee: Enzo Biochem, Inc.Inventors: Elazar Rabbani, Jannis G. Stavrianopoulos, James J. Donegan, Dakai Liu, Norman E. Keller, Dean L. Engelhardt
-
Patent number: 8735146Abstract: There is described a method of isolating nucleotide sequences encoding target peptides from DNA libraries using DNA binding proteins to link the peptide to the sequence which encodes it. DNA libraries are prepared from cells encoding the protein of interest, or from synthetic DNA, and inserted into, or adjacent to, a DNA binding protein in an expression vector to create a chimeric fusion protein. Incorporation of the vector DNA into a carrier package, during expression of the chimeric fusion protein, results in the production of a peptide display carrier package (PDCP) displaying the DNA-bound fusion protein on the external surface of the carrier package. Employment of affinity purification techniques results in the PDCP particles containing sequences encoding the desired peptide to be selected and the desired nucleotide sequences obtained therefrom.Type: GrantFiled: November 13, 2007Date of Patent: May 27, 2014Assignee: The University Court of the University of AberdeenInventor: Duncan McGregor
-
Patent number: 8735147Abstract: The invention provides novel cyclotide polypeptides, and variants and fragments thereof, obtained from Butterfly pea and having pesticidal activity against nematodes. Particular embodiments of the invention provide isolated nucleic acids encoding pesticidal proteins, biopesticide compositions, expression cassettes, and transformed microorganisms and plants comprising a nucleic acid of the invention. These compositions find use in methods for controlling pests, especially plant-parasitic pests such as nematodes and insects.Type: GrantFiled: April 4, 2012Date of Patent: May 27, 2014Assignee: Pioneer Hi Bred International IncInventors: Daniel J. Altier, Xuehua Hu, Daniel L. Siehl, Jun-Zhi Wei, Gusui Wu
-
Patent number: 8735148Abstract: Disclosed herein are activated NK cells that exhibit durable and prolonged activity in the absence of the activating agent and retain their activated state after preservation. Methods of administrating the NK cells to a patient do not require co-administration of the activating agent, and thus, pharmaceutical compositions comprising the NK cells may remain substantially free of the activating agent.Type: GrantFiled: July 9, 2010Date of Patent: May 27, 2014Assignee: UCL Business PLCInventor: Mark Lowdell
-
Patent number: 8735149Abstract: Provided is a method for directing differentiation of neural progenitors with a caudal and ventral specification into motor neurons including culturing neural progenitors in a culturing medium including a basic medium supplemented by at least one inhibitor of the Notch signaling pathway whereby the neural progenitors differentiate into postmitotic motor neurons. The resulting motor neurons may be used for drug development, as carriers, e.g. for gene therapy of protein delivery as well as for transplantation for the purpose of treating a motor neuron disease.Type: GrantFiled: April 5, 2009Date of Patent: May 27, 2014Assignee: Hadasit Medical Research Services & Development LimitedInventors: Benjamin Reubinoff, Etti Ben Shushan, Michal Aharonowiz
-
Patent number: 8735150Abstract: The present invention relates to methods of detecting, in a sample, embryonic stem cells, induced pluripotent stem cells, and/or cells undergoing reprogramming to produce induced pluripotent stem cells. These methods include providing a sample potentially containing such cells and providing a rosamine derivative compound of the formula (I): where the rosamine derivative compound selectively produces fluorescent signals for embryonic stem cells, induced pluripotent stem cells, and/or cells undergoing reprogramming to produce induced pluripotent stem cells. These methods also include the steps of contacting the sample with the rosamine derivative compound and detecting the presence of the embryonic stem cells, induced pluripotent stem cells, and/or cells undergoing reprogramming to produce induced pluripotent stem cells based on fluorescent signals emitted by the sample following said contacting.Type: GrantFiled: August 22, 2011Date of Patent: May 27, 2014Assignees: New York University, National University of Singapore, Agency for Science, Technology & ResearchInventors: Young-Tae Chang, Hyung Ho Ha, Nam Young Kang, Seong Wook Yun, Sung Jin Park, Young-Hoon Ahn
-
Patent number: 8735151Abstract: The invention relates to an in vitro method for producing spontaneously contracting fish cell aggregates, to the fish cell aggregates obtained thereby, and to the use thereof, in particular for testing biological active substances and pharmaceuticals. The in vitro method according to the invention for producing contracting fish cell aggregates comprises the following steps: a) mechanical comminution and/or partial enzymatic digestion of fish embryos or fish larvae; b) transfer of the comminuted and/or partially digested fish tissue into an enzyme-free medium and removing the supernatant by centrifuging to obtain a cell pellet; c) re-suspension of the cell pellet in a cell culture medium; d) culturing the cells, with the medium being changed at least once, until spontaneously contracting cell aggregates form.Type: GrantFiled: September 8, 2010Date of Patent: May 27, 2014Assignee: Fraunhofer-Gesellschaft zur Foerderung der Angewandten Forschung E.V.Inventors: Charli Kruse, Bianka Grunow, Daniel Hans Rapoport, Philipp Ciba
-
Patent number: 8735152Abstract: The present invention has as its object developing a method that does not involve genomic modification and which yet is capable of inducing cell death in pluripotent stem cells such as embryonic stem cells and induced pluripotent stem cells, as well as in differentiated cells other than cardiomyocytes derived from pluripotent stem cells, but not in cardiomyocytes. It has been revealed that by establishing a method capable of inducing cell death in cells other than cardiomyocytes in a very efficient manner by adding a substance having no recognized inherent toxicity or cell death inducing action to the culture conditions for pluripotent stem cells and non-cardiomyocytes, the stated problem can be solved without relying upon genomic modification.Type: GrantFiled: March 29, 2010Date of Patent: May 27, 2014Assignees: Daiichi Sankyo Company, Limited, Keio UniversityInventors: Fumiyuki Hattori, Keiichi Fukuda
-
Patent number: 8735153Abstract: Methods and compositions for modifying stem cells using one or more ZFPs are disclosed. Such methods and compositions are useful for facilitating processes such as, for example, dedifferentiating cells, differentiating stems cells into the desired phenotype, propagating stem cells and/or facilitating cloning.Type: GrantFiled: September 24, 2002Date of Patent: May 27, 2014Assignee: Sangamo BioSciences, Inc.Inventors: Michael Moore, Timothy Farries, Trevor Collingwood, Fyodor Urnov, Elizabeth J. Wolffe
-
Patent number: 8735154Abstract: A scaffold having islet cells or small islet cell clusters attached thereto in a multilayer, and a micro-mold having divots for culturing islets, wherein islet formation is influenced by the shape and dimensions of the divots are disclosed.Type: GrantFiled: April 6, 2010Date of Patent: May 27, 2014Assignee: The University of KansasInventors: Cory Berkland, Lisa A. Stehno-Bittel, Teruna Siahaan, Karthik Ramachandran
-
Patent number: 8735155Abstract: Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition may also include an extracellular matrix scaffold component of any formulation, and further include added cells, proteins, or other components to optimize the regenerative process and restore cardiac function.Type: GrantFiled: September 27, 2013Date of Patent: May 27, 2014Assignee: CorMatrix Cardiovascular, Inc.Inventor: Robert G Matheny
-
Patent number: 8735156Abstract: A spermatogonial stem cell line that is derived from testes of rats characterized by a desirable genetic background can serve as a source for cells to transplant into male-sterile recipient animals that are immuno-compatible with the spermatogonial line. Rat cells thus transplanted readily develop into fertilization-competent, haploid male gametes, with little or no endogenous sperm competition generated by the testes of the male-sterile recipient. This approach, constituting the first vector system for the use of rat spermatogonial lines from in vitro culture in generating mutant rats on a desired genetic background, effects maximal germline transmission of donor haplotypes from the transplanted spermatogonial cells.Type: GrantFiled: December 1, 2009Date of Patent: May 27, 2014Inventor: Franklin Kent Hamra
-
Patent number: 8735157Abstract: The presently described technology relates to the modulation of specific immune responses to create a protective immunity in the treatment of autoimmune diseases and diseases requiring the transplantation of tissue. In particular, the present technology relates to the suppression of immune responses in a targeted fashion, by increasing the functional concentration of the CEACAM1 protein in a target tissue to create a localized protective immunity for the treatment of autoimmune diseases and diseases requiring the transplantation of tissue.Type: GrantFiled: June 9, 2006Date of Patent: May 27, 2014Inventor: Gal Markel
-
Patent number: 8735158Abstract: Methods for the targeted integration of nucleotide sequences into a plant are provided. Transfer cassettes comprising nucleotide sequences of interest flanked by non-identical recombination sites are used to transform a plant comprising a target site. The target site contains at least a set of non-identical recombination sites corresponding to those on the transfer cassette. Exchange of the nucleotide sequences flanked by the recombination sites is effected by a recombinase.Type: GrantFiled: February 28, 2008Date of Patent: May 27, 2014Assignee: Pioneer Hi-Bred International, Inc.Inventors: Christopher L. Baszczynski, Benjamin A. Bowen, David J. Peterson, Laura Tagliani
-
Patent number: 8735159Abstract: The present invention relates to the use of nucleic acid sequences for regulating the transcription and expression of genes, the novel promoters and expression units themselves, methods for altering or causing the transcription rate and/or expression rate of genes, expression cassettes comprising the expression units, genetically modified microorganisms with altered or caused transcription rate and/or expression rate, and methods for preparing biosynthetic products by cultivating the genetically modified microorganisms.Type: GrantFiled: March 17, 2008Date of Patent: May 27, 2014Assignee: BASF SEInventors: Oskar Zelder, Corinna Klopprogge, Burkhard Kroger, Hartwig Schroder, Stefan Haefner
-
Patent number: 8735160Abstract: The present invention provides a method of targeted mutagenesis in Gram-positive bacteria. In particular, the present invention provides a method that effectively integrates a suicide integrative vector into a target gene in the chromosome of a Gram-positive bacterium, resulting in inactivation of the target gene.Type: GrantFiled: September 19, 2008Date of Patent: May 27, 2014Assignee: UT-Battelle, LLCInventor: Yunfeng Yang
-
Patent number: 8735161Abstract: The disclosure provides sensor for gas sensing including CO2 gas sensors comprising a porous framework sensing area for binding an analyte gas.Type: GrantFiled: July 8, 2013Date of Patent: May 27, 2014Assignees: The Regents of the University of California, BASF SEInventors: Omar M. Yaghi, Alexander U. Czaja, Bo Wang, Kosmas Galatsis, Kang L. Wang, Hiroyasu Furukawa
-
Patent number: 8735162Abstract: This disclosure relates to a process for controlling chlorination reactions in manufacturing titanium tetrachloride in a fluidized bed reactor, followed by processing to form a titanium product comprising an amount of silica, the process comprising: (a) feeding carbonaceous material, titanium bearing material comprising an amount of silica, and chlorine to the fluidized bed reactor to form a gaseous stream, and condensing the gaseous stream to form titanium tetrachloride, a non-condensed gas stream and a condensable product stream; (b) processing the titanium tetrachloride to form a titanium product comprising an amount of silica; (c) analyzing the titanium product comprising an amount of silica to determine the analyzed concentration of silica; (d) identifying a set point concentration of silica; (e) calculating the difference between the analyzed concentration of silica and the set point concentration of silica; (f) measuring the titanium tetrachloride flow to a processing reactor that releases chlorine; (gType: GrantFiled: September 2, 2010Date of Patent: May 27, 2014Assignee: E I du Pont de Nemours and CompanyInventors: James Elliott Merkle, Jr., Raymond Roy Beets, Jr.
-
Patent number: 8735163Abstract: A blood coagulation system analyzing method includes acquiring information relating to the coagulability of blood based on a change generated in a complex permittivity spectrum measured in a coagulation process of the blood due to addition of a substance that activates or inactivates platelets to the blood.Type: GrantFiled: February 23, 2012Date of Patent: May 27, 2014Assignee: Sony CorporationInventors: Yoshito Hayashi, MarcAurele Brun, Shinji Omori, Yoichi Katsumoto, Kazumasa Sato
-
Patent number: 8735164Abstract: The present invention relates to a fluoride distillation apparatus and a method for quantifying sodium monofluorophosphate among fluorides using the same, which increases the acid resistance of the hard tissues of the teeth and promotes remineralization of initial caries lesion.Type: GrantFiled: November 19, 2010Date of Patent: May 27, 2014Assignee: Amorepacific CorporationInventors: Sang Chul Park, Boo Min Kim, Ji Hee Jung, Min Kee Kim, Hye Jin Jeong
-
Patent number: 8735165Abstract: A sensor, a method for its fabrication, and a method for its use to detect contaminants, for example, ammonia, in stagnant and dynamic fluid media, especially liquid media. The sensor is an opto-chemical sensor that includes a polymer optical fiber, a sensing layer comprising oxazine 170 perchlorate on the polymer optical fiber, and a membrane layer on the sensing layer. The membrane layer is gas permeable and not permeable to the fluid in the fluid system, and moisture is entrapped by and between the sensing and membrane layers.Type: GrantFiled: May 14, 2012Date of Patent: May 27, 2014Assignee: Purdue Research FoundationInventors: Agbai Agwu Nnanna, Ahmed Hasnain Jalal
-
Patent number: 8735166Abstract: Compositions containing polyanthrylene and methods of making these compositions are disclosed herein. The polyanthrylene composition can, for example, be used for detection of iron in a sample.Type: GrantFiled: April 7, 2011Date of Patent: May 27, 2014Assignee: Tongji UniversityInventors: Mei-rong Huang, Shao-jun Huang, Jiang-Ying Li, Xin-gui Li
-
Patent number: 8735167Abstract: Provided is a photoamplified fluorescence turn-off assay where a masked photosensitizer is mixed with a fluorescent molecule. This mixture is brightly fluorescent because the masked photosensitizer is not capable of quenching the fluorophore. When the photosensitizer is released and amplified, the photosensitizer quenches the emission of fluorophores very efficiently.Type: GrantFiled: August 20, 2008Date of Patent: May 27, 2014Assignee: Colorado Seminary, which owns and operates The University of DenverInventors: Andrei G. Kutateladze, Alexei Kurchan, Rudresha Kottani, Janaki Majjigapu
-
Patent number: 8735168Abstract: This document provides methods and materials involved in removing polypeptides (e.g., high abundance polypeptides) from stool samples. For example, methods and materials for preparing a stool sample for detecting polypeptides of low abundance are provided. For example, this document provides methods and materials for depleting abundant polypeptides common to stool from normal, healthy humans from a stool sample. Such depleted stool samples can be used to detect polypeptides of interest such as low abundance polypeptides or neoplasm-specific polypeptide markers that can be present in a mammal suffering from a disease such as cancer.Type: GrantFiled: November 21, 2008Date of Patent: May 27, 2014Assignee: Mayo Foundation for Medical Education and ResearchInventors: David A. Ahlquist, Harold R. Bergen, Patrick S. Quint, Jonathan J. Harrington
-
Patent number: 8735169Abstract: The present invention generally relates methods for analyzing agricultural and/or environmental samples using liquid bridges. In certain embodiments, the invention provides a method for analyzing an agricultural sample for a desired trait including obtaining a gene or gene product from an agricultural sample, in which the gene or gene product is in a first fluid; providing a liquid bridge for mixing the gene or gene product with at least one reagent to form a mixed droplet that is wrapped in an immiscible second fluid; and analyzing the mixed droplet to detect a desired trait of the agricultural sample.Type: GrantFiled: May 20, 2009Date of Patent: May 27, 2014Assignee: Stokes Bio LimitedInventors: Mark Davies, Tara Dalton
-
Patent number: 8735170Abstract: A biogenic substance concentration measuring apparatus includes an optical measuring apparatus for measuring optical properties of a first substrate and a second substrate by using a cell for biogenic substance concentration measurement that includes: the first substrate on which a plurality of first metallic nanorods, each of which is modified with a substance that bonds specifically to a test substance, are immobilized such that the long axes thereof are aligned in the same direction; and the second substrate on which a plurality of second metallic nanorods, each of which is modified with a blocking substance, are immobilized such that the long axes thereof are aligned perpendicularly to the long axes of the first metallic nanorods on the first substrate, and calculates a biogenic substance concentration with high accuracy from the optical properties.Type: GrantFiled: May 30, 2012Date of Patent: May 27, 2014Assignee: Panasonic CorporationInventors: Masaru Minamiguchi, Tatsurou Kawamura, Masahiko Shioi, Atsushi Matsubara
-
Patent number: 8735171Abstract: The present invention relates to a method for determining the redox status of a cell or tissue comprising a step consisting of determining the level of PML nuclear bodies in said cell or tissue.Type: GrantFiled: January 13, 2011Date of Patent: May 27, 2014Assignee: Institut National de la Santé et de la Recherche Médicale (INSERM)Inventors: Hugues De The, Valerie Lallemand-Breitenbach
-
Patent number: 8735172Abstract: The present invention relates to a method for the manipulation for an identification purpose of a microcarrier comprising the steps of: (a) an identification purpose step of the microcarrier; and (b) a positioning and orientation step prior to or during the identification purpose step, wherein the identification purpose step is a detection step for the detection of an encoded microcarrier having an anisotropy in its shape. The invention further relates to an apparatus for the manipulation for identification purposes of a microcarrier comprising means for identification purposes such as a microscope and means for the positioning and orientation of the microcarriers.Type: GrantFiled: September 22, 2010Date of Patent: May 27, 2014Assignee: Biocartis S.A.Inventors: Marc Jan René Leblans, Emmanuel Marie Paul Ernest Gustin, Christiaan Hubert Simon Roelant, Joseph Demeester, Stefaan Cornelis De Smedt, Kevin Braeckmans
-
Patent number: 8735173Abstract: A novel protein profiling method of testing for Lysosomal Storage Diseases (“LSD”) using discovered normalized lysosomal fingerprint patterns. The fingerprint patterns reveal the health of lysosomal organelles, specific LSD, and clinical severity. Multiplexing bead technology for simultaneous screening of multiple LSD and normalizing measured enzyme activity or protein levels against other lysosomal proteins, enzymes, or enzyme activities. Compounds, reagents, and methods for identifying and quantifying multiple target enzymes and proteins.Type: GrantFiled: March 28, 2012Date of Patent: May 27, 2014Assignee: Women's and Children's HospitalInventors: Peter John Meikle, John Joseph Hopwood, Douglas Alexander Brooks, Caroline Dean
-
Patent number: 8735174Abstract: Coated colloidal materials, methods for making coated colloidal materials, and methods of using coated colloidal materials are disclosed. The method yields coated colloidal materials where the optical characteristics of the core is not adversely affected. The coated colloidal materials can be self-assembled into films, layers, or structures and used in the detection of analytes through detection assays.Type: GrantFiled: July 23, 2008Date of Patent: May 27, 2014Assignee: Northwestern UniversityInventors: Chad A. Mirkin, Xiaodong Chen, Can Xue, Sarah J. Hurst
-
Patent number: 8735175Abstract: The present invention relates to the use of multiple different light emitting molecules that emit different and detectable emission signals to provide systems and methods to detect different target products in a single assay sample, wherein the different light emitting molecules are positioned an optimal distance from metallic particles thereby enhancing emissions. Preferably, the systems and methods further comprise use of either microwave or sonic energy to increase binding reactions, timing of such reactions within the assay sample and reduce background non-specific biological absorption.Type: GrantFiled: March 15, 2012Date of Patent: May 27, 2014Inventor: Chris D. Geddes
-
Patent number: 8735176Abstract: The present invention relates to a metal oxide nano-composite magnetic material, fabrication method, and method for linkage, enrichment, and isolation of phosphorylated species. The metal oxide nano-composite magnetic material comprises the magnetic iron oxide nanoparticle, a silica layer immobilized onto the magnetic iron oxide nanoparticle and a metal oxide layer coated onto the silica layer. The magnetic iron oxide nanoparticles can be used for absorbing microwave radiation to accelerate the enrichment and linkage for phosphorylated species onto the metal oxide nano-composite magnetic material. Furthermore, the magnetic property of magnetic iron oxide nanoparticles leads to isolation of the metal oxide nano-composite magnetic material-target species conjugates by simply employing an external magnetic field.Type: GrantFiled: April 11, 2008Date of Patent: May 27, 2014Assignee: National Chiao Tung UniversityInventors: Yu-Chie Chen, Cheng-Tai Chen, Wei-Yu Chen, Chun-Yuen Lo, Hong-Yi Lin, Chih-Chi Liu
-
Patent number: 8735177Abstract: A diagnostic marker is composed of particles that have a diameter of from 1 nm to 100 ?m, the particles possessing on their surfaces a site that has a high specific bonding ability to a specific antigen residing on the mucosa of digestive cancers and a site that has a low bonding ability to the mucosa of digestive organs, and further incorporating an identification material.Type: GrantFiled: February 20, 2007Date of Patent: May 27, 2014Assignee: Adeka CorporationInventors: Shinji Sakuma, Shinji Yamashita, Ken-Ichiro Hiwatari, Yoshikazu Shoji
-
Patent number: 8735178Abstract: Novel withanolide chemical genetic probes identify the in vivo binding target of withaferin A, which is the intermediate filament type III protein vimentin. In addition, a withanolide-based small molecule screening method screens drug candidates that target intermediate filament type III proteins. The method includes introducing a tagged linker covalently bonded to the withanolide molecule to form a withanolide probe. Better or alternative small molecule compounds as potential drug candidates can be generated based on their likely affinity for the determined binding site in vimentin. The affinity labeled withanolide can also be used to find intermediate filament-associated proteins using chemical proteomics by extracting proteins from cells that were exposed to withanolide-biotin analog. The withanolide probes can be used to monitor expression of vimentin, in tumor samples or other diseased tissues.Type: GrantFiled: February 14, 2007Date of Patent: May 27, 2014Assignee: University of Kentucky Research FoundationInventors: Royce Mohan, Paola Bargagna-Mohan, Kyung Bo Kim
-
Patent number: 8735179Abstract: A magnetic tunnel junction (MTJ) device and fabrication method is disclosed. In a particular embodiment, a method of forming a magnetic tunnel junction (MTJ) device includes forming a top electrode layer over an MTJ structure. The top electrode layer includes a first nitrified metal.Type: GrantFiled: September 11, 2009Date of Patent: May 27, 2014Assignee: QUALCOMM IncorporatedInventors: Xia Li, Seung H. Kang
-
Patent number: 8735180Abstract: A stacking apparatus that stacks chip assemblies each having a plurality of chips disposed continuously with circuit patterns and electrodes, includes: a plurality of stages each allowed to move arbitrarily, on which the chip assemblies are placed; a storage unit that stores an estimated extent of change in a position of an electrode at each chip, expected to occur as heat is applied to the chip assemblies placed on the plurality of stages during a stacking process; and a control unit that sets positions of the plurality of stages to be assumed relative to each other during the stacking process based upon the estimated extent of change in the position of the electrode at each chip provided from the storage unit and position information indicating positions of individual chips formed at the chip assemblies and controls at least one of the plurality of stages.Type: GrantFiled: April 15, 2013Date of Patent: May 27, 2014Assignee: Nikon CorporationInventor: Kazuya Okamoto